Market News
Roche’s $5.3B Obesity Drug Deal Unveiled
Roche’s $5.3B bet on Zealand’s petrelintide could redefine obesity treatment. Will it outshine giants like Novo Nordisk? Click to uncover...
02/05/2025
0 views